Arcturus Therapeutics :
ARCT
ARCT
Stock Data
$8.63
$0.01 (0.12%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Arcturus Therapeutics Holdings Inc is a biotechnology firm based in San Diego, California, specializing in the development of innovative mRNA medicines and vaccines. With a focus on addressing infectious diseases, liver, and respiratory rare conditions, Arcturus leverages its proprietary LUNAR lipid-mediated delivery and STARR mRNA technology platforms. The company's pipeline includes ARCT-810, a treatment for ornithine transcarbamylase deficiency in Phase 2 trials, ARCT-154, a COVID-19 vaccine candidate in Phase 3 trials in Vietnam, and ARCT-032, a potential therapy for cystic fibrosis.
All Arcturus Therapeutics Articles
11 Articles